These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2783690)

  • 1. Physiological studies of the regulation of beta-lactamase expression in Pseudomonas maltophilia.
    Rosta S; Mett H
    J Bacteriol; 1989 Jan; 171(1):483-7. PubMed ID: 2783690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of beta-lactamase production in Pseudomonas maltophilia, a nosocomial pathogen.
    Cullmann W; Dick W
    Chemotherapy; 1990; 36(2):117-26. PubMed ID: 2311440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants.
    Mett H; Rosta S; Schacher B; Frei R
    Rev Infect Dis; 1988; 10(4):765-9. PubMed ID: 3263685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M
    Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal diversity and metallo-beta-lactamase production in clinical isolates of Stenotrophomonas maltophilia.
    Mercuri PS; Ishii Y; Ma L; Rossolini GM; Luzzaro F; Amicosante G; Franceschini N; Frere JM; Galleni M
    Microb Drug Resist; 2002; 8(3):193-200. PubMed ID: 12363008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to beta-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 beta-lactamases.
    Akova M; Bonfiglio G; Livermore DM
    J Med Microbiol; 1991 Oct; 35(4):208-13. PubMed ID: 1941990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and laboratory significance of inducible beta-lactamases].
    Bedenić B; Zagar Z
    Lijec Vjesn; 1995; 117(9-10):249-53. PubMed ID: 8643019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of mrcA gene derepresses the basal-level expression of L1 and L2 β-lactamases in Stenotrophomonas maltophilia.
    Lin CW; Lin HC; Huang YW; Chung TC; Yang TC
    J Antimicrob Chemother; 2011 Sep; 66(9):2033-7. PubMed ID: 21719470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinicomicrobiological study on the importance of pseudomonas in nosocomially infected ICU patients, with special reference to metallo beta1-lactamase production.
    Sarkar B; Biswas D; Prasad R; Sharma JP
    Indian J Pathol Microbiol; 2006 Jan; 49(1):44-8. PubMed ID: 16625977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of AmpR in regulation of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia.
    Lin CW; Huang YW; Hu RM; Chiang KH; Yang TC
    Res Microbiol; 2009 Mar; 160(2):152-8. PubMed ID: 19071216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.
    Okazaki A; Avison MB
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1525-8. PubMed ID: 18212097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of beta-lactamase in Proteus vulgaris.
    Okonogi K; Kuno M; Higashide E
    J Gen Microbiol; 1986 Jan; 132(1):143-50. PubMed ID: 3519851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactamase induction by imipenem in Yersinia enterocolitica.
    Pham JN; Bell SM
    Pathology; 1992 Jul; 24(3):201-4. PubMed ID: 1437295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
    Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K
    Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible oxacillin-hydrolyzing beta-lactamase in a methylotrophic bacterium.
    Samuelov NS; Citri N
    Biochim Biophys Acta; 1988 Jan; 952(1):48-55. PubMed ID: 3257141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of chromosomal beta-lactamase expression in enterobacteria.
    Lindberg F; Lindquist S; Normark S
    J Antimicrob Chemother; 1986 Oct; 18 Suppl C():43-50. PubMed ID: 3542940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of clinical isolate of Stenotrophomonas maltophilia with blaNDM-1, blaL1 and blaL2 β-lactamase genes under imipenem treatment.
    Liu W; Zou D; Wang X; Li X; Zhu L; Yin Z; Yang Z; Wei X; Han L; Wang Y; Shao C; Wang S; He X; Liu D; Liu F; Wang J; Huang L; Yuan J
    J Proteome Res; 2012 Aug; 11(8):4024-33. PubMed ID: 22702735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
    Hechler U; van den Weghe M; Martin HH; Frère JM
    J Gen Microbiol; 1989 May; 135(5):1275-90. PubMed ID: 2695600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoxitin sensitivity as a marker for inducible beta-lactamases.
    Moritz VA; Carson PB
    J Med Microbiol; 1986 May; 21(3):203-7. PubMed ID: 3486293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.